Skip to main content
. Author manuscript; available in PMC: 2013 Dec 24.
Published in final edited form as: Ann Rheum Dis. 2012 Sep 6;72(6):10.1136/annrheumdis-2012-201810. doi: 10.1136/annrheumdis-2012-201810

Table 3. Risk of cartilage loss at 30 months for subregions with baseline cartilage score of 0 by grade of prevalent baseline damage severity.

Cartilage morphology status Subregions without adjacent pathology TF1 Subregions with adjacent pathology TF1
Reference: Grade 0 and 1 combined: Subregions with cartilage loss at follow-up 180/7286 (2.47) 172/2461 (7.0)
aOR3 1.0 (reference) 1.0 (reference)
Grade2.0: Subregions with cartilage loss at FU 66/ 292 (22.6) 67/184 (36.4)
aOR3 11.3 7.74
95% CI (8.06,16.0) (5.43,11.06)
p <.0001* <.0001*
Grade 2.5: Subregions with cartilage loss at FU 11/103 (10.7) 23/70 (32.9)
aOR3 4.83 6.49
95% CI (2.49,9.38) (3.67,11.48)
p <.0001* <.0001*
Grade 3: Subregions with cartilage loss at FU 106/753 (14.1) 321/1230 (26.1)
aOR3 6.53 4.38
95% CI (4.78,9.38) (3.44,5.57)
p <.0001* <.0001*
Grade 4: Subregions with cartilage loss at FU 1/9 (11.1) 10/40 (25.0)
aOR3 4.94 3.43
95% CI (0.80,30.58) (1.62,7.27)
p 0.09 0.01*
Grades 5 and 6 combined: Subregions with cartilage loss at FU 11/148 (7.4) 151/948 (15.9)
aOR3 3.27 2.18
95% CI (1.60,6.71) (1.62,2.92)
p 0.001 <.0001*
*

significant at p <0.05

1

adjacent pathology: meniscal damage and/or meniscal extrusion and/or bone marrow lesion

3

adjusted for age, gender, BMI, malalignment, radiographic OA severity, Hoffa-synovitis, effusion-synovitis

TF- tibio-femoral, PF – patello-femoral, FU – follow-up, aOR – adjusted odds ratio, 95% CI – 95% confidence interval